Checkmate Pharmaceuticals, Inc.: operating_income
| Value | {"amount": -8271000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-04-01 – 2020-06-30 |
| Status | current |
| Entity | Checkmate Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e2c607f3-3c8b-4a69-af45-5692764fc724
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-20-249120 · Open the official SEC filing →Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001651431/operating-income/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e2c607f3-3c8b-4a69-af45-5692764fc724
History
- no predecessors — first report